Clinical Trial Update: To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating Z-338 for functional dyspepsia, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Z-338

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED